Efficacy of Escitalopram in Pain, Anxiety, and Depressive Symptoms of Patients with Breast Cancer: A Randomized Single-Blind Controlled Trial

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NIKBAKHSH NOVIN; Hasani Zohreh; Azizi Alireza; ZABIHI EBRAHIM; GHANBARI ATEFEH; Salehian Razieh; MOUDI SUSSAN

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Red Crescent Medical Journal Year:2021 | Volume:23 | Issue:7 Page(s): 0-0

Download Full-Text

View:

140

Download:

180

Cites:

Information Journal Paper

Title

Efficacy of Escitalopram in Pain, Anxiety, and Depressive Symptoms of Patients with Breast Cancer: A Randomized Single-Blind Controlled Trial

Author(s)

Keywords

Anxiety

Breast neoplasms

Depression

Pain

Abstract

Background: Pain, Anxiety, and Depression are common but often neglected problems in patients with cancer. Objectives: Considering the importance and impact of Anxiety and Depression as common psychiatric symptoms in people with cancer, the present study aimed to assess the effectiveness of escitalopram in the reduction of Pain, Anxiety, and Depression in patients with breast cancer. Methods: This single-blind controlled trial was conducted on 32 patients diagnosed with breast cancer who were referred for modified radical mastectomy (2018-2019). The intervention group received daily oral capsules containing 10 milligrams of escitalopram for four weeks, while the control group received placebo capsules containing starch on a daily basis. Hospital Anxiety and Depression Scale (HADS) and Visual Analogue Scale were administered to the patients at the commencement of the study and four weeks after the intervention. In addition, at baseline examination, personality factors were assessed by the NEO Five-Factor Inventory-3 questionnaire. Results: Based on the results, the scores of HADS Anxiety, total HADS, and Pain reduced after the intervention in the case group; however, the HADS Depression score demonstrated a slight increase. A significant difference was observed between the case and control groups for HADS Anxiety score after the intervention (P=0. 01). The correlation of personality characteristics with HADS Anxiety and Depression subscales pointed out a significant negative correlation between the HADS Depression score and conscientiousness (r=-0. 40; P<0. 05). Conclusion: Due to minor side effects of escitalopram, this drug is suggested to be used for the reduction of Anxiety symptoms and Pain intensity in patients with breast cancer.

Cites

No record.

References

Cite

APA: Copy

NIKBAKHSH, NOVIN, Hasani, Zohreh, Azizi, Alireza, ZABIHI, EBRAHIM, GHANBARI, ATEFEH, Salehian, Razieh, & MOUDI, SUSSAN. (2021). Efficacy of Escitalopram in Pain, Anxiety, and Depressive Symptoms of Patients with Breast Cancer: A Randomized Single-Blind Controlled Trial. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 23(7), 0-0. SID. https://sid.ir/paper/704471/en

Vancouver: Copy

NIKBAKHSH NOVIN, Hasani Zohreh, Azizi Alireza, ZABIHI EBRAHIM, GHANBARI ATEFEH, Salehian Razieh, MOUDI SUSSAN. Efficacy of Escitalopram in Pain, Anxiety, and Depressive Symptoms of Patients with Breast Cancer: A Randomized Single-Blind Controlled Trial. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2021;23(7):0-0. Available from: https://sid.ir/paper/704471/en

IEEE: Copy

NOVIN NIKBAKHSH, Zohreh Hasani, Alireza Azizi, EBRAHIM ZABIHI, ATEFEH GHANBARI, Razieh Salehian, and SUSSAN MOUDI, “Efficacy of Escitalopram in Pain, Anxiety, and Depressive Symptoms of Patients with Breast Cancer: A Randomized Single-Blind Controlled Trial,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 23, no. 7, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/704471/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops